Education
About Us
Working with TipRanks
Follow Us
COSMOS Pharmaceutical Corporation (JP:3349)
:3349
RESEARCH TOOLSreports
Total Valuation
COSMOS Pharmaceutical Corporation has a market cap or net worth of ¥647.78B. The enterprise value is ¥571.86B.
Market Cap¥647.78B
Enterprise Value¥571.86B
Share Statistics
COSMOS Pharmaceutical Corporation has 80.00M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding80.00M
Owned by Insiders
Owned by Instutions
Financial Efficiency
COSMOS Pharmaceutical Corporation’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee¥175,070,573.295
Profits Per Employee¥4,436,502.177
Employee Count5,512
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of COSMOS Pharmaceutical Corporation is ―. COSMOS Pharmaceutical Corporation’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, COSMOS Pharmaceutical Corporation had revenue of ¥964.99B and earned ¥24.45B in profits. Earnings per share was ¥308.60.
Revenue¥964.99B
Gross Profit¥188.31B
Operating Income¥31.50B
Pretax Income¥33.72B
Net Income¥24.45B
EBITDA43.23B
Earnings Per Share (EPS)308.60
Cash Flow
In the last 12 months, operating cash flow was ¥18.82B and capital expenditures ¥0.00, giving a free cash flow of ¥18.82B billion.
Operating Cash Flow¥18.82B
Free Cash Flow¥18.82B
Free Cash Flow per Share¥235.20
Dividends & Yields
COSMOS Pharmaceutical Corporation pays an annual dividend of ¥32.50, resulting in a dividend yield of 0.77%
Dividend Per Share¥32.50
Dividend Yield0.77%
Payout Ratio8.08%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.26
52-Week Price Change19.42%
50-Day Moving Average7.28K
200-Day Moving Average7.05K
Relative Strength Index (RSI)73.07
Average Volume (3m)335.62K
Important Dates
COSMOS Pharmaceutical Corporation upcoming earnings date is Jul 11, 2025, TBA.
Last Earnings DateApr 14, 2025
Next Earnings DateJul 11, 2025
Ex-Dividend DateMay 29, 2025
Financial Position
COSMOS Pharmaceutical Corporation as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, COSMOS Pharmaceutical Corporation has paid ¥9.27B in taxes.
Income Tax¥9.27B
Effective Tax Rate―
Enterprise Valuation
COSMOS Pharmaceutical Corporation EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
COSMOS Pharmaceutical Corporation has ¥52.30B in cash and marketable securities with ¥34.06B in debt, giving a net cash position of -¥18.24B billion.
Cash & Marketable Securities¥52.30B
Total Debt¥34.06B
Net Cash-¥18.24B
Net Cash Per Share-¥227.97
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for COSMOS Pharmaceutical Corporation is ¥9266.67, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target¥9266.67
Price Target Upside13.87%
Analyst ConsensusModerate Buy
Analyst Count3
Revenue Growth Forecast10.49%
EPS Growth Forecast37.19%